Tag

psoriasis comorbidities

SOCU in the News: GLP-1 Agonists and Other Approaches

By Media Coverage

GLP-1 agonists

One of the most novel sessions at Skin of Color Update was a panel on the use of GLP-1 agonists and other multidisciplinary approaches in addressing the comorbidities associated with psoriasis and hidradenitis suppurativa. The American Journal of Managed Care wrote an article on the session, which discussed the relationship between obesity and inflammatory skin conditions.

Jennifer Soung, MD, FAAD, pointed out that adipose tissue is an active endocrine organ that releases cytokines that increase inflammation in the body. As outlined in the article, Dr. Soung noted the connection between obesity and psoriatic arthritis is strong as research has shown body mass index is related to the risk of psoriatic arthritis. Dr. Soung also stated that obesity may decrease biologic response.

Karan Lal, DO, MS, FAAD, addressed the systemic factors at play in hidradenitis suppurativa, and that dermatologists often become de-facto primary care providers for these patients. He outlined his approach for an initial office visit for the condition.

Both panelists also covered how to approach patients about their weight, including the value of asking for permission. Dr. Soung noted terminology to use that is more patient friendly. Drs. Soung and Lal shared current research on the impact of GLP-1 agonists on reducing disease severity and comorbidities as well as a potential direct anti-inflammatory effect.

Both Drs. Soung and Lal expressed the value of an interdisciplinary team, and encouraged dermatologists, if uncomfortable in prescribing GLP-1 agonists, to build referral relationships with physicians who address weight management.

Our sister conference, the ODAC Dermatology Conference, is continuing the GLP-1 conversation with a panel discussion that addresses safety of these medications, their impact on comorbidities, as well as aesthetic considerations. Dr. Soung will participate in the panel along with Dr. Steven Daveluy, Dr. Sarah Jackson, and ODAC Conference Co-Chair Dr. Adam Friedman. ODAC takes place in Orlando, January 16-19. Register today!

SOCU Faculty in the News: Dr. Karan Lal

By Skin of Color Update Agenda

pediatric psoriasis

Skin of Color Update faculty member Karan Lal, DO, FAAD, wrote the August cover story for Dermatology Times on the hidden burdens of pediatric psoriasis.

In the article, Dr. Lal addresses the need for early intervention and awareness of systemic comorbidities linked to pediatric psoriasis, including uveitis, arthritis, obesity, type 2 diabetes (T2D), and metabolic syndrome. Dr. Lal also comments on  available therapies and treatment obstacles in this patient population.

Dr. Lal will participate in an expert discussion at Skin of Color Update on addressing comorbidities in dermatologic disorders, including psoriasis and hidradenitis suppurativa. This discussion will also address the potential role of GLP-1 agonists. In addition, Dr. Lal will present on pediatric dermatology pearls for treating patients with skin of color.

Register for Skin of Color Update and attend lectures by premier experts in dermatology on topics that impact your patients.